Clinical Study
Effectiveness of a Novel Device in the Reduction of Cesarean Deliveries
Table 4
(Efforts to manage the cesarean delivery rate) adverse events (AEs) reported by treatment group.
| Summary | Treatment group | Fisher's Exact test P value | HEM-AVERT | Control |
| Number of patients | 50 | 48 | | Patients experiencing one or more AEs | 0 | 7 (14.6%) | 0.0053 | Patients experiencing one or more major AEs | 0 | 1 (2.1%) | 0.4898 | Adverse events by type | | | | Fetal bradycardia | 0 | 1 (2.1%) | 0.4898 | Hemorrhoids | 0 | 6 (12.5%) | 0.0117 | Right sulcus tear | 0 | 1 (2.1%) | 0.4898 |
|
|